Detalhe da pesquisa
1.
Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy.
Urol Int
; 105(3-4): 181-191, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33486494
2.
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages.
Urol Int
; 105(3-4): 169-180, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33412555
3.
Investigation on core-fucosylated prostate-specific antigen as a refined biomarker for differentiation of benign prostate hyperplasia and prostate cancer of different aggressiveness.
Tumour Biol
; 41(3): 1010428319827223, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30907281
4.
[Living with Localized Prostate Cancer - Decision-Making and Coping with the Illness]. / Leben mit einem lokal begrenzten Prostatakarzinom Entscheidungsfindung und Krankheitsverarbeitung.
Psychother Psychosom Med Psychol
; 68(11): 462-469, 2018 Nov.
Artigo
Alemão
| MEDLINE | ID: mdl-29351713
5.
Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy.
Int J Cancer
; 139(4): 749-53, 2016 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27038059
6.
Enabling or Cultivating? The Role of Prostate Cancer Patients' Received Partner Support and Self-Efficacy in the Maintenance of Pelvic Floor Exercise Following Tumor Surgery.
Ann Behav Med
; 50(2): 247-58, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26489842
7.
Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations.
Prostate
; 74(14): 1444-51, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25111659
8.
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma.
BMC Cancer
; 14: 372, 2014 May 26.
Artigo
Inglês
| MEDLINE | ID: mdl-24885955
9.
Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05).
BJU Int
; 113(3): 429-36, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24053564
10.
Comparison of surgical technique (open vs. laparoscopic) on pathological and long term functional outcomes following radical prostatectomy.
BMC Urol
; 14: 18, 2014 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-24506815
11.
Impact of thoracic epidural analgesia on blood loss in radical retropubic prostatectomy.
Urol Int
; 93(2): 193-201, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24851943
12.
Corpulence is the crucial factor: association of testosterone and/or obesity with prostate cancer stage.
Int J Urol
; 21(10): 980-6, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24865433
13.
High CRP values predict poor survival in patients with penile cancer.
BMC Cancer
; 13: 223, 2013 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-23642165
14.
Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer.
World J Urol
; 31(2): 253-9, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22763628
15.
Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer.
BMC Urol
; 13: 53, 2013 Oct 22.
Artigo
Inglês
| MEDLINE | ID: mdl-24148787
16.
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin.
BMC Med Inform Decis Mak
; 13: 83, 2013 Aug 05.
Artigo
Inglês
| MEDLINE | ID: mdl-23915212
17.
Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study.
Int J Urol
; 20(6): 585-92, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23176631
18.
Localization of FOXP3-positive cells in renal cell carcinoma.
Tumour Biol
; 33(2): 507-13, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22143939
19.
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients.
BMC Cancer
; 12: 399, 2012 Sep 08.
Artigo
Inglês
| MEDLINE | ID: mdl-22958305
20.
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells.
BMC Cancer
; 12: 130, 2012 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-22462810